pharma · Paroxysmal Supraventricular Tachycardia · Atrial Fibrillation · MIST
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a pharma organization headquartered in Montreal, CA. It trades on NYSE under ticker MIST. Primary therapeutic focus areas include Paroxysmal Supraventricular Tachycardia, Atrial Fibrillation,
Montreal, CA HQ
2007 Founded
123 Employees
Public company Type
MIST · NYSE Ticker
Company details
- Status
- Public
- HQ
- Montreal, CA
- Founded
- 2007
- Employees
- 123
- Programs
- 8
- Drugs
- 6
- Patents
- 12
Etripamil
Phase 2 · small molecule · Atrial Fibrillation
Etripamil for Atrial Fibrillation is a Phase 2 program (small_molecule) at Milestone Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code MSP-2017-5001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Milestone Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Atrial Fibrillation
- Status
- completed
- Trials
- 1